Isotoxic High-Dose Stereotactic Body Radiotherapy (iHD-SBRT) Versus Conventional Chemoradiotherapy for Localized Pancreatic Cancer: A Single Cancer Center Evaluation
Martin Manderlier(Université Libre de Bruxelles), Christelle Bouchart(Université Libre de Bruxelles), Jean Closset(Erasmus Hospital), Jean-Luc Engelholm(Université Libre de Bruxelles), Matthieu Hein(Université Libre de Bruxelles), Luigi Moretti(Université Libre de Bruxelles), Jean‐Luc Van Laethem(Deventer Ziekenhuis), Maria Antonietta Bali(Royal Marsden NHS Foundation Trust), Dirk Van Gestel(Université Libre de Bruxelles), Julie Navez(Université Libre de Bruxelles)
Cited by 22
Related Papers
Patient-derived organoids model treatment response of metastatic gastrointestinal cancers
|Science|2018|2.1k
Cancer of the pancreas: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
|Annals of Oncology|2015|1.3k
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
|The Lancet Oncology|2014|727
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines
|Journal of Crohn s and Colitis|2013|669
Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
|Journal of Clinical Oncology|2009|643